Ipilimumab vs Methylprednisolone Acetate
Ipilimumab vs Methylprednisolone Acetate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Methylprednisolone Acetate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Methylprednisolone Acetate β Small molecule.